PUBLIC CONTRACT · 2018
Aquisição de INFLIXIMAB 100 MG (BIOSSIMILAR) PÓ CONC SOL INJ FR IV (CPA N.º 2017/6 SPMS) - Processo de Aquisição IGIF N.º 11084918
- Contract value
- €55,440.00
- Signed on
- 22 June 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5909326PUBLISHED SUBJECT
Aquisição de INFLIXIMAB 100 MG (BIOSSIMILAR) PÓ CONC SOL INJ FR IV (CPA N.º 2017/6 SPMS) - Processo de Aquisição IGIF N.º 11084918
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PHARMAKERN PORTUGAL · Tax ID 507002571
Values and timeline
- Contract price
- €55,440.00
- Procedure base price
- €55,440.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 8 October 2019
- Award date
- 22 June 2018
- Signing date
- 22 June 2018
- Performance period
- 2 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33652000-5 - Antineoplásicos e imunomoduladores
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4199443
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.